Correlation Between Ono Pharmaceutical and Mega Uranium

Can any of the company-specific risk be diversified away by investing in both Ono Pharmaceutical and Mega Uranium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ono Pharmaceutical and Mega Uranium into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ono Pharmaceutical Co and Mega Uranium, you can compare the effects of market volatilities on Ono Pharmaceutical and Mega Uranium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ono Pharmaceutical with a short position of Mega Uranium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ono Pharmaceutical and Mega Uranium.

Diversification Opportunities for Ono Pharmaceutical and Mega Uranium

-0.71

Correlation Coefficient

Ono Pharmaceutical  Mega Uranium

Pay attention - limited upside

The 3 months correlation between Ono and Mega is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Ono Pharmaceutical Co and Mega Uranium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mega Uranium and Ono Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ono Pharmaceutical Co are associated (or correlated) with Mega Uranium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mega Uranium has no effect on the direction of Ono Pharmaceutical i.e., Ono Pharmaceutical and Mega Uranium go up and down completely randomly.

Pair Corralation between Ono Pharmaceutical and Mega Uranium

Assuming the 90 days horizon Ono Pharmaceutical Co is expected to under-perform the Mega Uranium. In addition to that, Ono Pharmaceutical is 1.39 times more volatile than Mega Uranium. It trades about -0.07 of its total potential returns per unit of risk. Mega Uranium is currently generating about 0.0 per unit of volatility. If you would invest  30.00  in Mega Uranium on September 14, 2024 and sell it today you would lose (6.00) from holding Mega Uranium or give up 20.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	26.91%
Values	Daily Returns

Ono Pharmaceutical Co  vs.  Mega Uranium

Ono Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ono Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Mega Uranium

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Mega Uranium are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Mega Uranium reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Ono Pharmaceutical and Mega Uranium

The main advantage of trading using opposite Ono Pharmaceutical and Mega Uranium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ono Pharmaceutical position performs unexpectedly, Mega Uranium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mega Uranium will offset losses from the drop in Mega Uranium's long position.

The idea behind Ono Pharmaceutical Co and Mega Uranium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.